LncRNA SNHG16 promotes Schwann cell proliferation and migration to repair sciatic nerve injury

被引:12
作者
Chen, Yujie [1 ,2 ]
Fan, Zhiying [1 ]
Dong, Qirong [1 ]
机构
[1] Soochow Univ, Dept Orthopaed, Affiliated Hosp 2, 1055 Sanxiang Rd, Suzhou 215004, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Sixth Peoples Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China
关键词
Sciatic nerve injury; Schwann cells (SCs); long non-coding RNA Snorna hostgene16 (LncRNA SNHG16); signal activator of transcription 3 (STAT3); cell migration; LONG NONCODING RNAS; EXPRESSION; CANCER;
D O I
10.21037/atm-21-3971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To investigate the expression of long non-coding RNA (lncRNA) Snorna hostgene16 (SNHG16) in sciatic nerve injury tissues and cells. The molecular mechanism of SNHG16 regulating signal activator of transcription 3 (STAT3) expression through "sponge" adsorption of miR-93-5p was also studied. Methods: A rat model of sciatic nerve injury was established, and primary Schwann cells (SCs) were extracted. The expression of SNHG16 in animal tissues with sciatic nerve injury and SCs treated with ischemia and hypoxia was detected by qPCR, and CCK-8 assay, cell scratch assay, and Transwell chamber assay were used to detect cell proliferation, migration, and invasion. The targeted binding of SNHG16 to miR-93-5p was verified by double luciferase reporter gene assay and miRNA immunoprecipitation assay. MiR-93-5p mimic, SNHG16 overexpression vector, and sh-STAT3 plasmid were transfected into cells, respectively, and the mRNA expressions of SNHG16, miR-93-5p, and STAT3 in the cells were detected by qPCR. Results: The expression of lncRNA SNHG16 was decreased after sciatic nerve injury, while overexpression of SNHG16 promoted the proliferation, migration, and invasion of SCs. The results of dual luciferase reporter gene assay and miRNA immunoprecipitation reaction showed miR-93-5p interacted with SNHG16, and the overexpression of miR-93-5p reversed the promoting effects of SNHG16 on the proliferation and invasion of SCs. At the same time, the knockdown of STAT3, which is the target gene of miR-93-5p, reversed the proliferation and invasion promotion effect of SNHG16 on SCs. SNHG16 affected the expression of its downstream target gene STAT3 by adsorbing miR-93-5p via endogenous competitive sponge. Conclusions: SNHG16 can regulate STAT3 expression by sponge adsorption of miR-93-5p in SCs, and SNHG16 and miR-93-5p can be used as potential targets for the diagnosis and treatment of sciatic nerve injury.
引用
收藏
页数:13
相关论文
共 30 条
  • [1] The Glia Response after Peripheral Nerve Injury: A Comparison between Schwann Cells and Olfactory Ensheathing Cells and Their Uses for Neural Regenerative Therapies
    Barton, Matthew J.
    St John, James
    Clarke, Mary
    Wright, Alison
    Ekberg, Jenny
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (02)
  • [2] SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5
    Cai, Chang
    Huo, Qiang
    Wang, Xiaolong
    Chen, Bing
    Yang, Qifeng
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 485 (02) : 272 - 278
  • [3] LncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancer
    Cao, Xianxiang
    Xu, Jing
    Yue, Dong
    [J]. CANCER GENE THERAPY, 2018, 25 (1-2) : 10 - 17
  • [4] SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism
    Christensen, Lise Lotte
    True, Kirsten
    Hamilton, Mark P.
    Nielsen, Morten M.
    Damas, Nkerorema D.
    Damggaard, Christian K.
    Ongen, Halit
    Dermitzakis, Emmanouil
    Bramsen, Jesper B.
    Pedersen, Jakob S.
    Lund, Anders H.
    Vang, Soren
    Stribolt, Katrine
    Madsen, Mogens R.
    Laurberg, Soren
    McGuire, Sean E.
    Orntoft, Torben F.
    Andersen, Claus L.
    [J]. MOLECULAR ONCOLOGY, 2016, 10 (08) : 1266 - 1282
  • [5] Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1
    Costigan, Michael
    Belfer, Inna
    Griffin, Robert S.
    Dai, Feng
    Barrett, Lee B.
    Coppola, Giovanni
    Wu, Tianxia
    Kiselycznyk, Carly
    Poddar, Minakshi
    Lu, Yan
    Diatchenko, Luda
    Smith, Shad
    Cobos, Enrique J.
    Zaykin, Dmitri
    Allchorne, Andrew
    Shen, Pei-Hong
    Nikolajsen, Lone
    Karppinen, Jaro
    Mannikko, Minna
    Kelempisioti, Anthi
    Goldman, David
    Maixner, William
    Geschwind, Daniel H.
    max, Mitchell B.
    Seltzer, Ze'ev
    woolf, Clifford J.
    [J]. BRAIN, 2010, 133 : 2519 - 2527
  • [6] Therapeutic strategies for peripheral nerve injury: decellularized nerve conduits and Schwann cell transplantation
    Han, Gong-Hai
    Peng, Jiang
    Liu, Ping
    Ding, Xiao
    Wei, Shuai
    Lu, Sheng
    Wang, Yu
    [J]. NEURAL REGENERATION RESEARCH, 2019, 14 (08) : 1343 - 1351
  • [7] Peripheral nerve injury arising in anaesthesia practice
    Hewson, D. W.
    Bedforth, N. M.
    Hardman, J. G.
    [J]. ANAESTHESIA, 2018, 73 : 51 - 60
  • [8] Efficient Schwann cell purification by differential cell detachment using multiplex collagenase treatment
    Jin, Yu-Qing
    Liu, Wei
    Hong, Tan-Hui
    Cao, Yilin
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2008, 170 (01) : 140 - 148
  • [9] miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma
    Kouri, Fotini M.
    Hurley, Lisa A.
    Daniel, Weston L.
    Day, Emily S.
    Hua, Youjia
    Hao, Liangliang
    Peng, Chian-Yu
    Merkel, Timothy J.
    Queisser, Markus A.
    Ritner, Carissa
    Zhang, Hailei
    James, C. David
    Sznajder, Jacob I.
    Chin, Lynda
    Giljohann, David A.
    Kessler, John A.
    Peter, Marcus E.
    Mirkin, Chad A.
    Stegh, Alexander H.
    [J]. GENES & DEVELOPMENT, 2015, 29 (07) : 732 - 745
  • [10] State-of-the-Art Techniques in Treating Peripheral Nerve Injury
    Kubiak, Carrie A.
    Kung, Theodore A.
    Brown, David L.
    Cederna, Paul S.
    Kemp, Stephen W. P.
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 2018, 141 (03) : 702 - 710